Skip to main content
#
 
Bookmark and Share
Client Login
Global Shipping Policies
Site Map
Contact
Cart
ProLine Blog
Link To Us
REWARDS
Product Search 
 
Client Login 
Email Address
Your Password
Forgot your password?
click here
 
Create an account
click here to create an account.
 I just wanted to say thanks for such great customer service on my recent order. I didn't expect to receive it so quickly after just placing the order the other day. This was my first order with your company but will not be my last. Thanks again..Darrin L (Arvada, CO)

Acetyl-L-Carnitine

Acetyl-L-carnitine is similar in form to the amino acidL-carnitine and also has some similar functions, such as being involved in the metabolism of food into energy.

The acetyl group that is part of acetyl-L-carnitine contributes to the production of the neurotransmitter acetylcholine, which is required for mental function. Several double-blind clinical trials suggest that acetyl-L-carnitine delays the progression of Alzheimers disease and enhances overall performance in some people with Alzheimers disease. Alzheimers research has been done with the acetyl-L-carnitine form, rather than the L-carnitine form, of this nutrient.

One double-blind trial4 has found that acetyl-L-carnitine may be helpful for people with degenerative cerebellar ataxia, a loss of muscular coordination caused by disease in the cerebellum (the hind part of the brain that controls muscle tone and balance).

Where is it found? Acetyl-L-carnitine is a molecule that occurs naturally in the brain, liver, and kidney. It is also available as a dietary supplement.

Refrences:

1. Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer�s disease. Neurobiol Aging 1995;16:1�4.

2. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer�s disease. Arch Neurol 1992;49:1137�41.

3. Cucinotta D, Passeri M, Ventura S, et al. Multicenter clinical placebo-controlled study with acetyl-L-carnitine (LAC) in the treatment of mildly demented elderly patients. Drug Development Res 1988;14:213�6.

4. Sorbi S, Forleo P, Fani C, Piacentini S. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Clin Neuropharmacol 2000;23:114�8.

5. No authors listed. Acetyl-L-Carnitine. Altern Med Rev 1999;4:438�41 [review].

6. Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer�s disease. Neurology 1996;47:705�11.

7. Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer�s dementia. Curr Med Res Opin 1990;11:638�47.

Resources for Today's Endurance Athletes ®

Copyright © 2023 ProLine Sports Nutrition, Inc. ®

Email Customer Care

Disclaimer: While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on this website. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this Website is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. ProLine Sports Nutrition, Inc. ®